Short interfering RNAs (siRNAs) have engendered much enthusiasm for their ability to silence expression of specific genes. However, it is now well established that siRNAs, depending on their sequence, can be variably sensed by the innate immune system through recruitment of tolllike receptors 7 and 8 (TLR7/8). Here we aimed to identify sequence-based modifications allowing for the design of bifunctional siRNAs with both pro-inflammatory and specific silencing activities, and with potentially increased therapeutic benefits as antiviral or antitumor agents. We found that the introduction of a micro-RNA-like non-pairing uridine-bulge in the passenger strand robustly increased immunostimulatory activity on human immune cells. This sequence modification had no effect on the silencing efficiency of the siRNA. Increased immunostimulation with the uridine-bulge design was specific to human cells, and conserved silencing efficiency required a Dicer-substrate scaffold. The increased cytokine production with the uridine-bulge design resulted in enhanced protection against Semliki Forest virus infection, in viral assays. Thus, we characterize for the first time a design scaffold applicable to any given siRNA sequence, that results in increased innate immune activation without affecting gene silencing. This sequence coupled with structural modification differentially recruits human TLR8 over TLR7, and could have potential application in antiviral therapies.
INTRODUCTION
RNA interference (RNAi) is an evolutionarily conserved antiviral mechanism that relies on short molecules of double-stranded RNA (dsRNA) of 21-23 base pairs (bp), known as short interfering RNAs (siRNAs). Among species, the hallmark of RNAi is its specificity, affecting only the expression of the target gene sharing perfect homology with the siRNA sequence. Several siRNAs targeting disease-causing genes are currently in clinical trials, and the therapeutic potential of these double-stranded oligoribonucleotides is extensive. 1 However, we and others have shown that siRNAs can be sensed by the mammalian immune system, compromising the specificity of silencing. [2] [3] [4] In addition to the recognition of low-molecular-mass synthetic agonists such as imidazoquinolines, toll-like receptors 7 and 8 (TLR7/8) can sense single-stranded RNAs (ssRNAs) and siRNAs in a sequence-specific manner. 2, 3, 5 Recent publications indicate that short
RNAs can be differentially sensed by TLR7 and TLR8, according to their sequence. 6, 7 The expression of these receptors is restricted to certain blood immune cell subtypes, including human plasmacytoid dendritic cells (pDCs) which express the highest levels of TLR7, and human monocytes/macrophages which express the highest levels of TLR8. 8 Systemic delivery of siRNA in vivo is intrinsically related to a potential recruitment of these immune cells, as both TLR7 and 8 are located in the endosomal compartment and can sense endocytosed ssRNA/dsRNA. 9 TLR7
activation in pDCs preferentially induces interferon-α (IFN-α) production, whereas TLR8 activation in monocytes/macrophages results in production of tumor necrosis factor-α (TNF-α) and interleukin-12(p70) (IL-12(p70)). 10 While immune activation caused by siRNAs was unanticipated and is a cause of concern, 11 backbone modifications have been developed that dampen activation of an immune response. [12] [13] [14] However, we have previously proposed that it might be therapeutically beneficial to design siRNAs that provoke an enhanced immune response and enhance siRNA-mediated antiviral and antitumor therapy. 11 Indeed, proof of principle of a "bifunctional" siRNA approach of combining gene silencing and immunostimulation demonstrating antitumoral synergy between innate immune recruitment and gene-specific targeting has recently published. 15 However, this study relied on a 5'-triphosphate modification of siRNA and activation of innate immunity via retinoic acid-inducible gene I (RIG-I). 15 To date, there are several reports that certain motifs in siRNA duplexes specifically induce TLR7/8, 2, 3 and detailed studies of 19-21 nucleotide (nt) single-stranded RNAs have identified different motifs that promote TLR7/8 recruitment ( 6 , European patents EP1764107 and EP1764108). While useful, determination of immunostimulatory motifs in each individual strand of an siRNA is a poor predictor of the immunostimulatory potential of the resulting duplex ( 4 , 16 and Gantier and Williams, unpublished). Importantly, rational design of efficient siRNAs remains predictive, and in most cases only a few siRNAs can be confirmed to promote strong silencing.
Selection of siRNAs based on criteria of both RNAi efficiency and sequenced-based immunostimulatory potential may compromise one or other parameter. To our knowledge, there is currently no modification described that can be applied to a given siRNA duplex to increase its ability to recruit TLR7/8 without impacting on its gene silencing efficiency. Here we characterize a micro-RNA (miRNA)-like sequence modification that robustly increases immunostimulation of three independent Dicer-substrate siRNAs (D-siRNAs). This modification did not impact on silencing efficiency of the duplexes, and likely involves specific TLR8 recruitment.
RESULTS

Structural/sequence requirements of short RNAs for TLR7/8 activation
We and others have previously demonstrated that TLR7/8 sensing of short RNAs is uridine dependent. 5, 7, 17 However, our previous findings also indicated that the position of the uridine residues within the secondary structure of an ssRNA could impact on immunostimulation. 7 To further characterize the impact of secondary structure of ssRNAs on TLR7/8 recruitment, we used a rational approach to increase the predicted self-complementarity of an ssRNA previously shown to activate both IFN-α and TNF-α in human peripheral blood mononuclear cells (PBMCs), without affecting its uridine content (B-406-AS 7 ) (Fig. 1a and Table 1 suggested that TLR8 (as measured through TNF-α production) was more sensitive to the secondary structure of an ssRNA than TLR7 (measured through IFN-α production). In parallel, we also assessed the net impact of uridine content in an ssRNA with low self-secondary structure, independent of structure variation ( Fig. 1c and Table 1 ). In accord with uridine-dependent TLR7/8 sensing, both IFN-α and TNF-α were induced in a dose-dependent manner with increasing uridines (Fig. 1d , compare ss41-N and ss41-4/6/8/10). At the doses of ssRNA used (90 nM), a minimum of four uridines was required to detect immunostimulation (see ss41-4, for TNF-α), consistent with our previous observations (see SC and SB ssRNAs 7 ). However, more than eight uridines did not result in any further increase in cytokine production (compare ss41-8 and ss41-10, for IFN-α and TNF-α, Fig. 1d ). Collectively, these results support a role for both uridine content and secondary structure in TLR7/8 sensing of ssRNAs.
Rational design of immunostimulatory siRNAs
To study the impact of uridine content and secondary structure of siRNA duplexes on both immunostimulation and silencing efficiency, we used a rational approach affecting the sequence of siRNA duplexes. While siRNAs are conventionally designed as 21-23 bp duplexes to mimic Dicer products, it has been shown that dsRNAs that are long enough to be treated as Dicer substrates (D-siRNAs) can also promote RNAi in mammalian cells. 18, 19 Further, using an asymmetric D-siRNA of 25/27 nt with both blunt and 3' overhang ends helps to mimic the natural substrates of mammalian Dicer (i.e. pre-miRNA hairpins) and allows for increased directional processing and selection of the guide strand of the siRNA. 18, 19 The 3' end of an asymmetric D-siRNA (using the passenger strand as a reference) is preferentially cleaved by Dicer and should have little impact on sequence-specific silencing. 18 Accordingly, a set of three D-siRNAs was synthesized with increased uridines in the region predicted to be cleaved by Dicer (siLam-1, siLam-2, siLam-3, Fig. 2a ). Noting that TLR8 may be sensitive to the secondary structure of ssRNAs ( Fig. 1 ), we designed a Dicer substrate with a miR-29a-like uridine-bulge on the passenger strand (position 9-12), predicting that this modification would not alter Dicer processing and strand selection (siLam-4, Fig. 2a ). These siRNAs were derived from a previously validated D-siRNA sequence targeting the human LaminA/C (LMNA) mRNA (M. Behlke, unpublished). Unexpectedly, when assayed for immunostimulation in human PBMCs, a decrease in IFN-α and/or TNF-α levels with siLam-1 and siLam-2 was observed when compared to the native siLam control (Fig. 2b) . Nevertheless, both siLam-3 and siLam-4 promoted a significant increase in IFN-α and/or TNF-α production. In HEK 293T cells, siLam-2 and siLam-4 both silenced LaminA/C mRNA expression with equal efficacy to the control sequence, but the other approaches were less effective (Fig. 2c) . siLam-4 silencing efficacy was confirmed by measuring
LaminA/C mRNA silencing by siLam-4 compared to control siLam-N in dose-response experiments (at 10 nM, 2 nM and 0.4 nM), where no significant differences were observed (not shown). These results indicated that the addition of an miRNA-like uridine-bulge to a D-siRNA scaffold resulted in increased immunostimulation without affecting RNAi activity.
Validation of the uridine-bulge siRNA design
In order to validate that the previous observations made with the siLam-4 design could be reproduced independently of the sequence of the duplex/target chosen, a D-siRNA targeting the enhanced green fluorescent protein (EGFP) was selected using the siRNA design software BIOPREDsi. 20 From the five best hits suggested by BIOPREDsi, the duplex with the least number of uridine residues was selected to minimize the basal immunostimulatory activity of the siRNA, and 6 nt complementary to the EGFP target added to make it a D-siRNA (Fig. 3e) . When comparing this EGFP D-siRNA with (siEGFP-U) or without (siEGFP) the bulge modification in immunostimulatory assays, a strong increase in TNF-α induction (>10 fold at 500 and 750 nM) and a significantly higher induction of IFN-α (at 500 nM) with the uridine-bulge modification was observed (Fig. 3a) . In addition, the uridine-bulge did not affect the ability of the EGFP DsiRNA to trigger RNAi in HEK 293T cells stably expressing EGFP (Fig. 3b) 
Uridine-bulge sensing is not conserved between human and mouse
The preferential induction of TNF-α over IFN-α with the uridine-bulge modification of all DsiRNAs suggested a predominant role for monocytes in sensing the bulge. To better define the immune cell subtype involved in the sensing of the modification, the ability of isolated CD14+
monocytes to respond to the uridine-bulge of siEGFP-U was assessed (Fig. 4a) . As anticipated, a significantly increased production of TNF-α was observed with the uridine-bulge D-siRNA (siEGFP-U) (>15 fold) in these cells. We have recently reported that human monocytic cells sense short RNAs through both TLR7 and TLR8 recruitment. 7 To further characterize the respective involvement of both receptors in the sensing of the uridine-bulge modification, we used mouse bone marrow derived macrophages (BMMs), in which ssRNA/siRNA sensing exclusively relies on TLR7 due to the lack of mouse TLR8 response to RNA agonists. 2, 5, 7 Unexpectedly, the uridine-bulge modification inhibited rather than promoted the immunostimulatory effect of the siEGFP D-siRNA, as measured by TNF-α production (Fig. 4b ).
While this implicates human TLR8 in sensing of the uridine-bulge modification, it precludes using murine-based disease models to measure potential therapeutic benefits of the uridine-bulge modification.
Pro-inflammatory/antiviral effects of uridine-bulge modification
We next looked to elucidate the cytokine profile induced by the uridine-bulge modification of the Use of uridine-bulge modification with 21 bp siRNA scaffold siβ-Gal-924 is a 21 bp siRNA duplex targeting the β-galactosidase mRNA, demonstrating silencing efficiency but low immunostimulatory potential in human PBMCs. 3 To define whether the uridine-bulge modification could also be applied independently of the Dicer-substrate scaffold, we synthesized siβ-Gal-924 and its uridine-bulge variant (siβ-Gal-924-U,
Supplementary Table S1 ) and tested for immunostimulation and down-regulation efficiency. In agreement with our previous results, the uridine-bulge modification of siβ-Gal-924 promoted significant induction of TNF-α and IFN-α in human PBMCs, compared to its native variant ( Fig.   7a ). Nevertheless, in HEK 293T cells transiently expressing β-galactosidase, the down-regulation efficiency of siβ-Gal-924 was reduced (~10%) by the uridine-bulge modification, indicating an adverse effect of the modification on RNAi recruitment (Fig. 7b ). Of note, siβ-Gal-478 promoted stronger down-regulation of β-galactosidase than siβ-Gal-924, as previously reported.
3
DISCUSSION
The innate immune system is the first line of defense against infection with viruses or pathogens.
Sensing of specific pathogen-associated molecular patterns (PAMPs) by innate immune receptors such as the TLRs, is followed by the induction of a targeted response limiting the infection. As key mediators of this response, IFNs coordinate the expression of hundreds of antiviral genes. In this work, we sought to develop siRNAs with enhanced immunostimulatory potential via TLR7/8 activation. The finding that TNF-α but not IFN-α was strongly induced when self-complementarity was added to a single-stranded short RNA in human PBMCs (Fig. 1b) , led us to speculate that TLR7 and TLR8 sensing of short RNAs is governed by a different sensing of secondary structures. Further, the observation that the introduction of an miRNA-like uridinebulge in the middle of an siRNA duplex consistently induced increased immunostimulation in human monocytes (Fig. 4a) but not in mouse macrophages (Fig. 4b) , suggests that human TLR8
and not TLR7, is the sensor of the uridine-bulge modification. In agreement with this, a recent study by Ablasser et al. showed a TLR8-activation-dependent increase in production of IL-12(p70), following introduction of mismatches in the strands of an siRNA duplex. positively correlated with increased immunostimulatory activity. 31 The results from our three distinct siRNA duplexes are unequivocal: addition of the uridine-bulge promotes increased TNF-α, IFN-γ, IL-1β, and the Th1 polarizing IL-12(p70) (Fig. 5) . However, we also observed possible saturation in the immunostimulation conferred by the uridine-bulge with one siRNA sequence exhibiting high basal immunostimulatory potential ( Supplementary Fig. S1 -compare siEGFP-U 500 nM and siBcl2l12-N 250 nM). Based on these results, we propose that the addition of the uridine-bulge modification will increase pro-inflammatory activation of any given siRNA sequence that is not already strongly immunostimulatory, most likely through human TLR8.
The measurement of both mRNA and protein levels of targeted genes indicated that while the uridine-bulge did not impact on the silencing efficiency of any of the Dicer-substrate siRNAs studied (Figs. 2c, 3b and 3d) , it significantly inhibited RNAi when used in the context of a 21 bp siRNA scaffold (Fig. 7b) . Relying on the consistent observation that the bulge did not alter silencing on three different D-siRNAs, it is unlikely that the difference observed with the shorter β-galactosidase uridine-siRNA is simply related to this particular sequence. Because the two scaffold designs compared here differ only from one another by their position in the Dicer processing step (i.e. upstream or downstream of Dicer), it can be speculated that Dicer processing and direct recruitment of the bulge-siRNA is required for correct unwinding and RNA induced silencing complex (RISC) loading of the imperfect miRNA-like siRNA duplex. However, it could also be argued that the lower affinity of the two strands destabilizes the 21 bp bulge β-galactosidase siRNA duplex and renders it more prone to degradation, while the longer conformation of the D-siRNAs would confer protection. Our observation that the bulge modification of the D-siRNAs did not affect RNAi efficiency when compared to a perfectly pairing duplex was unexpected. It is currently thought that perfectly pairing duplexes undergo Ago2 processing of the passenger strand, 32 while miRNA-like imperfect duplexes would be unwound through an elusive helicase. 33 The finding that similar RNAi efficiency can be achieved regardless of the affinity of the two strands of a D-siRNA highlights the concept that Ago2-RISC cleavage efficiency of the complementary target is not affected by the nature of the prior degradation or unwinding of the passenger strand of the duplex, when Dicer is involved in active RISC formation. Further in-depth investigations of the role of Dicer in the recruitment of RNAi by bulge-modified siRNAs with the two scaffold designs should help better characterize the previous findings, and could be informative in the design of better miRNA mimics.
SFV is a single-stranded positive-sense Alphavirus that induces apoptosis of continuously cultured cells 24-48 hours after infection. 34 SFV is particularly sensitive to IFN pre-treatment of cells prior to infection. 35 Here we found that conditioned media from human PBMCs treated with a uridine-bulge D-siRNA conferred increased protection to SFV infection of Hela cells, when compared to a perfect D-siRNA duplex (Fig. 6 ). This can be attributed to IFN-α production by the PBMCs and demonstrates that the increased immunostimulatory potential conferred by the uridine-bulge modification can have potent antiviral benefits. However, because the increased immunostimulatory effects of the uridine-bulge were not reproduced in mouse due to mouse TLR8 unresponsiveness to ss/siRNAs 5 ), we were unable to further characterize the benefits of the uridine-bulge modification in vivo.
In conclusion, we provide here the first rational design of a bifunctional D-siRNA scaffold, which can be applied to any given siRNA sequence. We demonstrate that the addition of an miRNA-like uridine-bulge to a Dicer substrate siRNA duplex confers increased immunostimulation in human PBMCs, with potential protective effect in viral infection. The bulge modification does not compromise RNAi recruitment and target-specific down-regulation, when used in a D-siRNA scaffold. Our data is indicative of a TLR8-preferential recruitment of short RNAs with loose secondary structure, including D-siRNAs with the uridine-bulge modification. Because it relies on a sequence modification, the uridine-bulge strategy presented in this work could be immediately amenable to large-scale industrial production of oligoribonuclotides, unlike other proposed modifications such as the 5'-triphosphate. 15 Combined target-specific delivery of bifunctional uridine-bulge D-siRNAs together with macrophage uptake performed following the manufacturer's guidelines. A standard curve was generated for each cytokine using a five-parameter logistic regression curve fit and analyzed concentrations were determined automatically using Bio-Plex Manager software (v4.01). All results below the detectable limit were recorded as zero, and those above the standard curve were assigned a value equal to the top standard. The native human Bcl2L12 (NM_138639) siRNA is inherently immunostimulatory. Human
MATERIALS AND METHODS
Cell
PBMCs were treated with indicated concentration of indicated siRNA complexed with DOTAP and incubated for 16 hours at 37°C. TNF-α concentration was measured by ELISA. The data is averaged from two independent experiments in biological triplicate from two blood donors.
Supplementary Table S1 Sequences of dsRNAs used in the study
Name Sequence
The uridine-bulge is highlighted in bold and the non-matching residues are underlined.
Uppercase letters are RNA bases and lowercase letters are DNA bases. 250 nM 500 nM 750 nM TNFα (pg/mL)
